查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530918

诱导多能干细胞市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Induced Pluripotent Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 156 Pages | 商品交期: 2-10个工作天内

价格

诱导性多能干细胞市场 - 报告范围

TMR 关于全球诱导多能干细胞市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 2034年干细胞市场，以2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球诱导多能干细胞市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解诱导多能干细胞市场。

市场概况
2023年市场价值 17 亿美元
2034 年市场价值 46 亿美元
复合年增长率 9.4%

该报告深入探讨了全球诱导多能干细胞市场的竞争格局。全球诱导多能干细胞市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球诱导多能干细胞市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按电池类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按电池类型，2020-2034
    • 肝细胞
    • 纤维母细胞
    • 角质形成细胞
    • 其他（神经元等）
  • 市场吸引力分析：按电池类型

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2020-2034
    • 药物开发
    • 再生医学
    • 毒性测试
    • 组织工程
    • 细胞疗法
    • 疾病建模
  • 市场吸引力分析：按应用

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 医院
    • 诊断中心
    • 製药与生物技术公司
    • 合约研究组织
    • 其他（学术研究机构等）
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Axol Bioscience
    • Cynata Therapeutics Limited
    • Evotec SE
    • Fate Therapeutics
    • FUJIFILM Cellular Dynamics, Inc.
    • Ncardia
    • LizarBio Therapeutics
    • REPROCELL Global
    • Sumitomo Dainippon Pharma Company Limited
    • Takara Bio USA, Inc.
    • Thermo Fisher Scientific
    • Vertex Pharmaceuticals
Product Code: TMRGL30530

Induced Pluripotent Stem Cells Market - Scope of Report

TMR's report on the global induced pluripotent stem cells market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global induced pluripotent stem cells market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global induced pluripotent stem cells market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the induced pluripotent stem cells market.

Market Snapshot
Market Value in 2023US$ 1.7 Bn
Market Value in 2034US$ 4.6 Bn
CAGR9.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global induced pluripotent stem cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global induced pluripotent stem cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global induced pluripotent stem cells market.

The report delves into the competitive landscape of the global induced pluripotent stem cells market. Key players operating in the global induced pluripotent stem cells market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global induced pluripotent stem cells market profiled in this report.

Key Questions Answered in Global induced pluripotent stem cells Market Report:

  • What is the sales/revenue generated by induced pluripotent stem cells across all regions during the forecast period?
  • What are the opportunities in the global induced pluripotent stem cells market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Induced Pluripotent Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global induced pluripotent stem cells market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global induced pluripotent stem cells market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global induced pluripotent stem cells market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Induced Pluripotent Stem Cells Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Induced Pluripotent Stem Cells Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Induced Pluripotent Stem Cells Market Analysis and Forecast, by Cell Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Cell Type, 2020-2034
    • 6.3.1. Hepatocytes
    • 6.3.2. Fibroblasts
    • 6.3.3. Keratinocytes
    • 6.3.4. Others (Neurons, etc.)
  • 6.4. Market Attractiveness Analysis, by Cell Type

7. Global Induced Pluripotent Stem Cells Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2034
    • 7.3.1. Drug Development
    • 7.3.2. Regenerative Medicine
    • 7.3.3. Toxicity Testing
    • 7.3.4. Tissue Engineering
    • 7.3.5. Cell Therapy
    • 7.3.6. Disease Modeling
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Induced Pluripotent Stem Cells Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Pharmaceutical & Biotechnology Companies
    • 8.3.4. Contract Research Organizations
    • 8.3.5. Others (Academic & Research Institutes, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Induced Pluripotent Stem Cells Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Induced Pluripotent Stem Cells Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Cell Type, 2020-2034
    • 10.3.1. Hepatocytes
    • 10.3.2. Fibroblasts
    • 10.3.3. Keratinocytes
    • 10.3.4. Others (Neurons, etc.)
  • 10.4. Market Value Forecast, by Application, 2020-2034
    • 10.4.1. Drug Development
    • 10.4.2. Regenerative Medicine
    • 10.4.3. Toxicity Testing
    • 10.4.4. Tissue Engineering
    • 10.4.5. Cell Therapy
    • 10.4.6. Disease Modeling
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostic Centers
    • 10.5.3. Pharmaceutical & Biotechnology Companies
    • 10.5.4. Contract Research Organizations
    • 10.5.5. Others (Academic & Research Institutes, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Cell Type
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Induced Pluripotent Stem Cells Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Cell Type, 2020-2034
    • 11.3.1. Hepatocytes
    • 11.3.2. Fibroblasts
    • 11.3.3. Keratinocytes
    • 11.3.4. Others (Neurons, etc.)
  • 11.4. Market Value Forecast, by Application, 2020-2034
    • 11.4.1. Drug Development
    • 11.4.2. Regenerative Medicine
    • 11.4.3. Toxicity Testing
    • 11.4.4. Tissue Engineering
    • 11.4.5. Cell Therapy
    • 11.4.6. Disease Modeling
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Pharmaceutical & Biotechnology Companies
    • 11.5.4. Contract Research Organizations
    • 11.5.5. Others (Academic & Research Institutes, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Cell Type
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Induced Pluripotent Stem Cells Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Cell Type, 2020-2034
    • 12.3.1. Hepatocytes
    • 12.3.2. Fibroblasts
    • 12.3.3. Keratinocytes
    • 12.3.4. Others (Neurons, etc.)
  • 12.4. Market Value Forecast, by Application, 2020-2034
    • 12.4.1. Drug Development
    • 12.4.2. Regenerative Medicine
    • 12.4.3. Toxicity Testing
    • 12.4.4. Tissue Engineering
    • 12.4.5. Cell Therapy
    • 12.4.6. Disease Modeling
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Pharmaceutical & Biotechnology Companies
    • 12.5.4. Contract Research Organizations
    • 12.5.5. Others (Academic & Research Institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Cell Type
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Induced Pluripotent Stem Cells Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Cell Type, 2020-2034
    • 13.3.1. Hepatocytes
    • 13.3.2. Fibroblasts
    • 13.3.3. Keratinocytes
    • 13.3.4. Others (Neurons, etc.)
  • 13.4. Market Value Forecast, by Application, 2020-2034
    • 13.4.1. Drug Development
    • 13.4.2. Regenerative Medicine
    • 13.4.3. Toxicity Testing
    • 13.4.4. Tissue Engineering
    • 13.4.5. Cell Therapy
    • 13.4.6. Disease Modeling
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Pharmaceutical & Biotechnology Companies
    • 13.5.4. Contract Research Organizations
    • 13.5.5. Others (Academic & Research Institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Cell Type
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Cell Type, 2020-2034
    • 14.3.1. Hepatocytes
    • 14.3.2. Fibroblasts
    • 14.3.3. Keratinocytes
    • 14.3.4. Others (Neurons, etc.)
  • 14.4. Market Value Forecast, by Application, 2020-2034
    • 14.4.1. Drug Development
    • 14.4.2. Regenerative Medicine
    • 14.4.3. Toxicity Testing
    • 14.4.4. Tissue Engineering
    • 14.4.5. Cell Therapy
    • 14.4.6. Disease Modeling
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Pharmaceutical & Biotechnology Companies
    • 14.5.4. Contract Research Organizations
    • 14.5.5. Others (Academic & Research Institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Cell Type
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Axol Bioscience
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Cynata Therapeutics Limited
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Evotec SE
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Fate Therapeutics
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. FUJIFILM Cellular Dynamics, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Ncardia
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. LizarBio Therapeutics
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. REPROCELL Global
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Sumitomo Dainippon Pharma Company Limited
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Takara Bio USA, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Thermo Fisher Scientific
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Vertex Pharmaceuticals
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview

List of Tables

  • Table 01: Global Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 02: Global Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 03: Global Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 07: North America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 08: North America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 11: Europe Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: Europe Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 15: Asia Pacific Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 19: Latin America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Cell Type, 2020-2034
  • Table 23: Middle East & Africa Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Induced Pluripotent Stem Cells Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Induced Pluripotent Stem Cells Market Revenue (US$ Bn), by Cell Type, 2023
  • Figure 03: Global Induced Pluripotent Stem Cells Market Value Share, by Cell Type, 2023
  • Figure 04: Global Induced Pluripotent Stem Cells Market Revenue (US$ Bn), by Application, 2023
  • Figure 05: Global Induced Pluripotent Stem Cells Market Value Share, by Application, 2023
  • Figure 06: Global Induced Pluripotent Stem Cells Market Revenue (US$ Bn), by End-user, 2023
  • Figure 07: Global Induced Pluripotent Stem Cells Market Value Share, by End-user, 2023
  • Figure 08: Global Induced Pluripotent Stem Cells Market Value Share, by Region, 2023
  • Figure 09: Global Induced Pluripotent Stem Cells Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 11: Global Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 13: Global Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 14: Global Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Induced Pluripotent Stem Cells Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Induced Pluripotent Stem Cells Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Induced Pluripotent Stem Cells Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 22: North America Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 23: North America Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 26: North America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Induced Pluripotent Stem Cells Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Induced Pluripotent Stem Cells Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 31: Europe Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 32: Europe Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 35: Europe Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Induced Pluripotent Stem Cells Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Induced Pluripotent Stem Cells Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 40: Asia Pacific Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 41: Asia Pacific Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 44: Asia Pacific Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Induced Pluripotent Stem Cells Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Induced Pluripotent Stem Cells Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 49: Latin America Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 50: Latin America Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Induced Pluripotent Stem Cells Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Induced Pluripotent Stem Cells Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Induced Pluripotent Stem Cells Market Value Share Analysis, by Cell Type, 2023 and 2034
  • Figure 58: Middle East & Africa Induced Pluripotent Stem Cells Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa Induced Pluripotent Stem Cells Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Induced Pluripotent Stem Cells Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 62: Middle East & Africa Induced Pluripotent Stem Cells Market Attractiveness Analysis, by End-user, 2024-2034